glp 1 agonist vision loss A potentially blinding condition is a very rare side effect of the GLP-1 receptor semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no GLP-1 Receptor Agonists and vision

Peptides offer targeted intervention addressing specific dark circle mechanisms through collagen synthesis improving skin thickness to obscure vessels, brightening compounds reducing melanin production, circulation enhancement reducing stagnant blood pooling, and anti-inflammatory effects decreasing puffiness and discoloration

But frequent glutathione is not recommended

Reported effects include hypoglycemia (substantial blood glucose drops), water retention, joint pain, and potential organ enlargement with chronic use

IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice

Korzystne dziaanie glutationu sprawia, e jest to zwizek, ktry moe zmniejsza ryzyko niektrych chorb